Sumyea Kabir: The Hidden Risk of Bombay Blood Group
Sumyea Kabir, Assistant Professor at Zainul Haque Sikder Women’s Medical College and Hospital, shared a post on LinkedIn:
”Bombay Blood Group (Oh): When ‘O’ Is Not O
A rare phenotype. A common mistake. A potentially fatal outcome.
During my residency at Bangladesh Medical University, I encountered 5 confirmed cases of Bombay blood group (Oh)—a powerful reminder that assumptions in blood grouping can cost lives.
The Dangerous Assumption:
- Appears as O group on forward typing
- considered universally compatible
O blood transfusion can cause acute hemolytic reaction
Apparent O is not equal to Safe O
Why named as ‘Bombay’ Blood Group?:
- First reported in 1952 in Bombay (Mumbai), India
- Discovery led to identification of absence of H antigen
- A landmark chapter in immunohematology—still clinically relevant today
What the Textbooks and Guidelines Say (Very Clearly):
Mollison’s Blood Transfusion:
- Forward grouping alone is dangerous
- Reverse grouping discrepancy is the key diagnostic clue
- Anti-H must be considered in apparent O groups
Denise Harmening:
- Bombay phenotype produces strong anti-H
- Incompatible with all ABO groups, including O
AABB Technical Manual:
- Both forward and reverse grouping are mandatory
- ABO discrepancies must be resolved before issue
- Rare blood groups must be documented and traceable
WHO Blood Safety Guidance:
- Emphasizes accurate grouping and antibody detection
- Strongly supports rare donor identification and registries
Classic Diagnostic Pattern (Do Not Miss!):
- Forward: anti-A negative | anti-B negative
- Reverse: A, B and O cells all positive
- Anti-H lectin: negative
- Diagnosis: Bombay blood group
Clinical Reality:
- Cannot receive A, B, AB or O blood
- Requires Bombay phenotype donor only
- Missed diagnosis leads to life-threatening reaction
What We MUST Build (System Responsibility):
- Permanent flagging of rare phenotypes
- Counseling and retention of rare donors
- 24/7 emergency donor contact lists
- Inter-hospital and regional networking
- National rare blood donor registry
Final Take-Home Message:
- No reverse grouping means no safe transfusion
- Bombay blood group is rare—but errors should never be
From MBBS textbooks to tertiary hospitals, the message is the same:
Details save lives in transfusion medicine.
Reference Figure (A)Shows agglutination reaction of the blood sample taken from an individual with an O-positive blood group, showing agglutination with anti-A and anti-B antisera, but no agglutination with anti-D and anti-H antisera.
(B) Represents the patient’s blood sample with an O-positive Bombay blood group which shows agglutination with anti-A, anti-B, and anti-H antisera, but no agglutination with anti-D antisera.”
Stay updated with Hemostasis Today.
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026
-
Jul 14, 2026, 12:02Louise St. Germain Bannon: Our first ISTH regulatory session at ISTH 2026
-
Jul 14, 2026, 11:21Malwina Maliszewska: Advancing Coagulation Diagnostics at ISTH 2026
-
Jul 14, 2026, 11:07Mary Cushman: Honoring Outstanding Mentorship at ISTH 2026
-
Jul 14, 2026, 10:53Maha Othman: Advancing the Management of Inherited Thrombocytopenias at ISTH 2026
-
Jul 14, 2026, 10:24Sara Zalghout: The Little Things That Make ISTH 2026 Special
-
Jul 14, 2026, 10:11Joseph R. Shaw: GAUGE Advances FXa Inhibitor Reversal at ISTH 2026
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation